Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Debt-to-Asset : 0.52 (As of Jan. 2020)

Cotinga Pharmaceuticals Debt-to-Asset Chart

Cotinga Pharmaceuticals Annual Data
	Trend	Apr10	Apr11	Apr12	Apr13	Apr14	Apr15	Apr16	Apr17	Apr18	Apr19
Debt-to-Asset		Get a 7-Day Free Trial					-	-	-	-	0.16

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Debt-to-Asset	Get a 7-Day Free Trial															-	0.16	0.19	0.36	0.52

Competitive Comparison of Cotinga Pharmaceuticals's Debt-to-Asset

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Debt-to-Asset falls into.

Cotinga Pharmaceuticals Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Cotinga Pharmaceuticals's Debt-to-Asset for the fiscal year that ended in Apr. 2019 is calculated as

Cotinga Pharmaceuticals's Debt-to-Asset for the quarter that ended in Jan. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cotinga Pharmaceuticals  (OTCPK:COTQF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Cotinga Pharmaceuticals Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description